Rabah A.T. Serya

1.2k total citations
38 papers, 1.0k citations indexed

About

Rabah A.T. Serya is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Rabah A.T. Serya has authored 38 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 26 papers in Molecular Biology, 18 papers in Organic Chemistry and 11 papers in Oncology. Recurrent topics in Rabah A.T. Serya's work include Synthesis and biological activity (11 papers), Cancer therapeutics and mechanisms (7 papers) and Quinazolinone synthesis and applications (7 papers). Rabah A.T. Serya is often cited by papers focused on Synthesis and biological activity (11 papers), Cancer therapeutics and mechanisms (7 papers) and Quinazolinone synthesis and applications (7 papers). Rabah A.T. Serya collaborates with scholars based in Egypt, United States and Saudi Arabia. Rabah A.T. Serya's co-authors include Khaled A. M. Abouzid, Deena S. Lasheen, Dalal A. Abou El Ella, Nasser S. M. Ismail, Amal Kamal Abdel‐Aziz, Ahmed Esmat, Eman M.E. Dokla, Ahmed M. Mansour, Abdel Nasser B. Singab and Mai F. Tolba and has published in prestigious journals such as SHILAP Revista de lepidopterología, Scientific Reports and Organic Letters.

In The Last Decade

Rabah A.T. Serya

37 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Rabah A.T. Serya Egypt 20 671 429 178 91 69 38 1.0k
Hesham A. M. Gomaa Saudi Arabia 19 759 1.1× 438 1.0× 173 1.0× 104 1.1× 47 0.7× 57 1.2k
Ashraf H. Bayoumi Egypt 25 1.1k 1.7× 538 1.3× 156 0.9× 141 1.5× 98 1.4× 50 1.4k
Meng Zhou China 21 497 0.7× 583 1.4× 135 0.8× 46 0.5× 29 0.4× 75 1.2k
Halil I. Ciftci Japan 19 500 0.7× 397 0.9× 109 0.6× 53 0.6× 32 0.5× 51 922
Mohammed A. Khedr Egypt 22 781 1.2× 325 0.8× 102 0.6× 91 1.0× 28 0.4× 59 1.1k
Riham F. George Egypt 25 1.2k 1.8× 576 1.3× 166 0.9× 167 1.8× 58 0.8× 76 1.6k
Saleh Ihmaid Saudi Arabia 24 884 1.3× 442 1.0× 119 0.7× 111 1.2× 35 0.5× 39 1.1k
Subhas S. Karki India 21 638 1.0× 696 1.6× 371 2.1× 53 0.6× 37 0.5× 80 1.5k
Rohan J. Meshram India 16 392 0.6× 330 0.8× 96 0.5× 97 1.1× 33 0.5× 48 877
Amer Ali Abd El‐Hafeez Egypt 15 304 0.5× 318 0.7× 159 0.9× 40 0.4× 38 0.6× 35 679

Countries citing papers authored by Rabah A.T. Serya

Since Specialization
Citations

This map shows the geographic impact of Rabah A.T. Serya's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rabah A.T. Serya with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rabah A.T. Serya more than expected).

Fields of papers citing papers by Rabah A.T. Serya

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rabah A.T. Serya. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rabah A.T. Serya. The network helps show where Rabah A.T. Serya may publish in the future.

Co-authorship network of co-authors of Rabah A.T. Serya

This figure shows the co-authorship network connecting the top 25 collaborators of Rabah A.T. Serya. A scholar is included among the top collaborators of Rabah A.T. Serya based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rabah A.T. Serya. Rabah A.T. Serya is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abdel‐Aziz, Amal Kamal, Eman M.E. Dokla, Marwa Sharaky, et al.. (2024). Novel sulfonamide-indolinone hybrids targeting mitochondrial respiration of breast cancer cells. European Journal of Medicinal Chemistry. 268. 116255–116255. 8 indexed citations
2.
Hassan, Ghaneya S., et al.. (2024). Advances in the discovery of activin receptor-like kinase 5 (ALK5) inhibitors. Bioorganic Chemistry. 147. 107332–107332. 2 indexed citations
3.
Serya, Rabah A.T., et al.. (2021). Synthesis and in vitro antiproliferative activity of certain novel pyrazolo[3,4‐b]pyridines with potential p38α MAPK‐inhibitory activity. Archiv der Pharmazie. 355(2). e2100302–e2100302. 11 indexed citations
4.
Dokla, Eman M.E., et al.. (2020). Penicillin binding protein 2a: An overview and a medicinal chemistry perspective. European Journal of Medicinal Chemistry. 199. 112312–112312. 94 indexed citations
5.
6.
Najm, Mazin A. A., et al.. (2019). Design, synthesis and molecular docking of novel pyrazolo[1,5-a][1,3,5]triazine derivatives as CDK2 inhibitors. Bioorganic Chemistry. 92. 103239–103239. 35 indexed citations
7.
Abdel‐Aziz, Amal Kamal, et al.. (2018). Surmounting the resistance against EGFR inhibitors through the development of thieno[2,3-d]pyrimidine-based dual EGFR/HER2 inhibitors. European Journal of Medicinal Chemistry. 155. 316–336. 61 indexed citations
8.
Serya, Rabah A.T., et al.. (2018). Synthesis and molecular docking studies of some novel Schiff bases incorporating 6-butylquinolinedione moiety as potential topoisomerase IIβ inhibitors. Royal Society Open Science. 5(6). 172407–172407. 18 indexed citations
9.
Mohammad, Haroon, Nader S. Abutaleb, Mohamed Hagras, et al.. (2018). Alkoxyphenylthiazoles with broad-spectrum activity against multidrug-resistant gram-positive bacterial pathogens. European Journal of Medicinal Chemistry. 152. 318–328. 29 indexed citations
10.
Serya, Rabah A.T., Mai F. Tolba, Marawan Ahmed, et al.. (2018). Design, synthesis, biological evaluation and dynamics simulation of indazole derivatives with antiangiogenic and antiproliferative anticancer activity. Bioorganic Chemistry. 82. 340–359. 40 indexed citations
11.
12.
Lasheen, Deena S., et al.. (2017). How to train your inhibitor: Design strategies to overcome resistance to Epidermal Growth Factor Receptor inhibitors. European Journal of Medicinal Chemistry. 142. 131–151. 56 indexed citations
13.
Debnath, Bikash, et al.. (2017). Synthesis, ADMET Properties, and Biological Evaluation of Benzothiazole Compounds Targeting Chemokine Receptor 2 (CXCR2). ChemMedChem. 12(13). 1045–1054. 9 indexed citations
14.
15.
Ismail, Nasser S. M., Riham F. George, Rabah A.T. Serya, et al.. (2016). Rational design, synthesis and 2D-QSAR studies of antiproliferative tropane-based compounds. RSC Advances. 6(104). 101911–101923. 23 indexed citations
16.
Serya, Rabah A.T., Deena S. Lasheen, Amal Kamal Abdel‐Aziz, et al.. (2016). Discovery of Potent VEGFR-2 Inhibitors based on Furopyrimidine and Thienopyrimidne Scaffolds as Cancer Targeting Agents. Scientific Reports. 6(1). 24460–24460. 150 indexed citations
17.
Serya, Rabah A.T., et al.. (2015). Synthesis and in vitro antiproliferative activity of novel pyrazolo[3,4- d ]pyrimidine derivatives. MedChemComm. 6(8). 1518–1534. 8 indexed citations
18.
Serya, Rabah A.T., et al.. (2015). Design, Synthesis and Biological Evaluation of Novel Quinazoline-Based Anti-inflammatory Agents Acting as PDE4B Inhibitors. Chemical and Pharmaceutical Bulletin. 63(2). 102–116. 14 indexed citations
19.
Elsayed, Mohamed, Moustafa E. El‐Araby, Rabah A.T. Serya, et al.. (2012). Structure-based design and synthesis of novel pseudosaccharine derivatives as antiproliferative agents and kinase inhibitors. European Journal of Medicinal Chemistry. 61. 122–131. 41 indexed citations
20.
Elsayed, Mohamed, Moustafa E. El‐Araby, Rabah A.T. Serya, & Khaled A. M. Abouzid. (2012). Virtual Screening and Synthesis of New Chemical Scaffolds as VEGFR-2 Kinase Inhibitors. Arzneimittelforschung. 62(12). 554–560. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Hesham A. M. Gomaa Breakdown of academic impact, for papers by Ashraf H. Bayoumi Breakdown of academic impact, for papers by Meng Zhou Breakdown of academic impact, for papers by Halil I. Ciftci Breakdown of academic impact, for papers by Mohammed A. Khedr Breakdown of academic impact, for papers by Riham F. George Breakdown of academic impact, for papers by Saleh Ihmaid Breakdown of academic impact, for papers by Subhas S. Karki Breakdown of academic impact, for papers by Rohan J. Meshram Breakdown of academic impact, for papers by Amer Ali Abd El‐Hafeez
Rankless by CCL
2026